MedPath

Assessment of ketogenic diet(KD) on blod lipid in patients with refractory epilepsy.

Not Applicable
Conditions
G40-G47
Refractory Epilepsy.
Episodic and paroxysmal disorders
Registration Number
IRCT2015042021607N2
Lead Sponsor
Vice Chancellor for research of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
33
Inclusion Criteria

refractory epilepsy ; don't have contraindicated ; Above 2 years old.
Exclusion criteria: inability to continue the ketogenic diet for 6 months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma lipid profil. Timepoint: Before treatment and at three and six month after treatment. Method of measurement: TG; Total Chol; HDL; LDL by mg/dl.
Secondary Outcome Measures
NameTimeMethod
Effect of KD on seizure control; urin random Ca; Cr; oxalate; uric acid; BLOOD ca; vitD; thyroid function tests; liver function tests; heart failure. Timepoint: Before treatment; 3 mounths; 6 months after treatment. Method of measurement: Seizure control by reduction in numbers of paroxysms; urine random Ca; urine random uric acid urinerandom oxalate; liver function tests; thyroid function tests; serum Ca and vit D by mg/dl; cardiovascular by ejection fraction that measured by litre per min.
© Copyright 2025. All Rights Reserved by MedPath